Melbourne Theranostic Innovation Centre (MTIC)
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hicks, Rod
MNPR-101-D001, NCT06337084: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Recruiting
1
12
RoW
Diagnostic Test: MNPR-101-DFO*-89Zr PET Scan
Monopar Therapeutics
Solid Tumor, Adult, Bladder Cancer, Urothelial Carcinoma, Triple-negative Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Ovarian Cancer, Pancreatic Cancer
04/25
06/25
NCT06471712: Clinical Study of 18F-LNC1007 Injection PET/CT

Not yet recruiting
1
8
RoW
18F-LNC1007 Injection
Yantai LNC Biotechnology Singapore PTE. LTD.
Healthy Volunteers, Cancer Patients
09/24
09/24
Coordinator, Referral
MNPR-101-D001, NCT06337084: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Recruiting
1
12
RoW
Diagnostic Test: MNPR-101-DFO*-89Zr PET Scan
Monopar Therapeutics
Solid Tumor, Adult, Bladder Cancer, Urothelial Carcinoma, Triple-negative Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Ovarian Cancer, Pancreatic Cancer
04/25
06/25

Download Options